These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37855302)

  • 1. Assessment and management of diabetes-related foot infection according to the new International Working Group on the Diabetic Foot guidelines 2023-Multidisciplinary grand rounds.
    Hon K; Nobels F; Senneville É; Uckay I; Maas M; Fitridge R
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3737. PubMed ID: 37855302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update).
    Schaper NC; van Netten JJ; Apelqvist J; Bus SA; Fitridge R; Game F; Monteiro-Soares M; Senneville E;
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3657. PubMed ID: 37243927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023).
    Senneville É; Albalawi Z; van Asten SA; Abbas ZG; Allison G; Aragón-Sánchez J; Embil JM; Lavery LA; Alhasan M; Oz O; Uçkay I; Urbančič-Rovan V; Xu ZR; Peters EJG
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3687. PubMed ID: 37779323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian guideline on management of diabetes-related foot infection: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.
    Commons RJ; Charles J; Cheney J; Lynar SA; Malone M; Raby E;
    J Foot Ankle Res; 2022 Jun; 15(1):47. PubMed ID: 35676695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update).
    Schaper NC; van Netten JJ; Apelqvist J; Bus SA; Hinchliffe RJ; Lipsky BA;
    Diabetes Metab Res Rev; 2020 Mar; 36 Suppl 1():e3266. PubMed ID: 32176447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standards for the development and methodology of the 2023 IWGDF guidelines.
    Bus SA; Monteiro-Soares M; Game F; van Netten JJ; Apelqvist J; Fitridge R; Senneville E; Schaper NC;
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3656. PubMed ID: 37179482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update).
    van Netten JJ; Bus SA; Apelqvist J; Chen P; Chuter V; Fitridge R; Game F; Hinchliffe RJ; Lazzarini PA; Mills J; Monteiro-Soares M; Peters EJG; Raspovic KM; Senneville E; Wukich DK; Schaper NC;
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3654. PubMed ID: 37186781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines.
    Bus SA; Van Netten JJ; Hinchliffe RJ; Apelqvist J; Lipsky BA; Schaper NC;
    Diabetes Metab Res Rev; 2020 Mar; 36 Suppl 1():e3267. PubMed ID: 31916377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of foot problems in diabetes: A Summary Guidance for Daily Practice 2015, based on the IWGDF guidance documents.
    Schaper NC; Van Netten JJ; Apelqvist J; Lipsky BA; Bakker K;
    Diabetes Res Clin Pract; 2017 Feb; 124():84-92. PubMed ID: 28119194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.
    Chuter V; Quigley F; Tosenovsky P; Ritter JC; Charles J; Cheney J; Fitridge R;
    J Foot Ankle Res; 2022 Jul; 15(1):51. PubMed ID: 35787293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique multidisciplinarity of diabetes-related foot disease.
    van Netten JJ; Apelqvist J; Bus SA; Fitridge R; Game F; Monteiro-Soares M; Senneville E; Schaper NC
    Diabetes Metab Res Rev; 2024 May; 40(4):e3804. PubMed ID: 38616492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines development protocol and findings: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease.
    Lazzarini PA; Raspovic A; Prentice J; Commons RJ; Fitridge RA; Charles J; Cheney J; Purcell N; Twigg SM;
    J Foot Ankle Res; 2022 Apr; 15(1):28. PubMed ID: 35440052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does the clinical practice of Aotearoa New Zealand podiatrists align with international guidelines for the prevention of diabetes-related foot disease? A cross-sectional survey.
    Jepson H; Lazzarini PA; Garrett M; Carroll MR
    J Foot Ankle Res; 2023 Aug; 16(1):53. PubMed ID: 37605269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus.
    Bakker K; Apelqvist J; Lipsky BA; Van Netten JJ;
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():2-6. PubMed ID: 26409930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease.
    van Netten JJ; Apelqvist J; Bus SA; Fitridge R; Game F; Monteiro-Soares M; Senneville E; Schaper NC
    Diabetes Ther; 2024 Jan; 15(1):19-31. PubMed ID: 37971638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.
    Fitridge R; Chuter V; Mills J; Hinchliffe R; Azuma N; Behrendt CA; Boyko EJ; Conte MS; Humphries M; Kirksey L; McGinigle KC; Nikol S; Nordanstig J; Rowe V; Russell D; van den Berg JC; Venermo M; Schaper N
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3686. PubMed ID: 37726988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of global consensus guidelines on the management of the diabetic foot.
    Apelqvist J; Bakker K; van Houtum WH; Schaper NC;
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S116-8. PubMed ID: 18442162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multidisciplinary management of diabetic foot ulcer infection].
    Blanchette V; Brousseau-Foley M
    Rev Med Interne; 2021 Mar; 42(3):193-201. PubMed ID: 33451819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents.
    Schaper NC; Van Netten JJ; Apelqvist J; Lipsky BA; Bakker K;
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():7-15. PubMed ID: 26335366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019).
    Monteiro-Soares M; Russell D; Boyko EJ; Jeffcoate W; Mills JL; Morbach S; Game F;
    Diabetes Metab Res Rev; 2020 Mar; 36 Suppl 1():e3273. PubMed ID: 32176445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.